Study Stopped
The first phase of the research has been completed
External Diaphragm Pacing Therapy and Correlation Analysis of Trunk Balance and Respiratory Function in Stroke Patients
1 other identifier
interventional
30
1 country
1
Brief Summary
The goal of this study is to observe the enhancement of trunk balance ability, pulmonary function, and diaphragm function in stroke patients after treatment of external diaphragm pacing(EDP), and analyze the potential correlation between trunk balance ability and respiratory function metrics. The main questions it aims to answer are:
- What is the effect of EDP treatment on trunk balance and respiratory function in stroke patients?
- Is there a correlation between trunk balance ability and respiratory function? Participants admitted to the Department of Rehabilitation Medicine at the First Affiliated Hospital of Anhui Medical University were randomly divided into an observation group and a control group:
- The control group received conventional rehabilitation therapy for 4 weeks.
- The observation group received EDP treatment in addition to conventional rehabilitation therapy for 4 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable stroke
Started Feb 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 13, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 14, 2023
CompletedFirst Submitted
Initial submission to the registry
December 13, 2023
CompletedFirst Posted
Study publicly available on registry
January 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2024
CompletedJanuary 10, 2024
December 1, 2023
6 months
December 13, 2023
December 27, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Forced Vital Capacity(FVC)
It is used to assess Respiratory function.FVC was evaluated using an exercise cardiopulmonary testing system (Nanjing Hanya Smax58ce).
Day 1 (before starting treatment) and 4 weeks later
Forced Expiratory Volume in 1 second (FEV1)
It is used to assess Respiratory function.FEV1 was evaluated using an exercise cardiopulmonary testing system (Nanjing Hanya Smax58ce).
Day 1 (before starting treatment) and 4 weeks later
Forced expiratory volume in 1 second as a percentage of forced vital capacity(FEV1/FVC)
It is used to assess Respiratory function.FEV1/FVC(%) was evaluated using an exercise cardiopulmonary testing system (Nanjing Hanya Smax58ce).
Day 1 (before starting treatment) and 4 weeks later
diaphragmatic excursion of deep breath(DE-DB)
It is used to assess Respiratory function.DE-DB was evaluated using Sonoson portable color ultrasound (M-Turbo).
Day 1 (before starting treatment) and 4 weeks later
Thickening Fraction(TF)
It is used to assess Respiratory function.TF was evaluated using Sonoson portable color ultrasound (M-Turbo).
Day 1 (before starting treatment) and 4 weeks later
diaphragmatic excursion of quiet breath(ED-QB)
It is used to assess Respiratory function.DE-QB was evaluated using Sonoson portable color ultrasound (M-Turbo).
Day 1 (before starting treatment) and 4 weeks later
the Modified Trunk Impairment Scale (mTIS)
It is used to assess trunk balance ability and includes the dynamic seated balance subscale (10 points) and the coordination subscale (6 points), with a total score of 16 points.
Day 1 (before starting treatment) and 4 weeks later
Study Arms (2)
control group
OTHERProvide participants with routine rehabilitation treatment
observation group
OTHERParticipants received EDP treatment on the basis of conventional rehabilitation treatment
Interventions
After the skin is disinfected, place the small electrode pads on the lower 1/3 of the outer edges of the sternocleidomastoid muscles on the left and right sides, and place the large electrodes on the surface of the pectoralis major muscles on both sides, and fix them with medical tape. Adjust the pacing according to the patient's tolerance. Frequency and stimulation intensity, each treatment time is 20 minutes, treatment is once a day, 5 days a week, and the treatment course is 4 weeks.
Participants received comprehensive rehabilitation treatments such as muscle strength training, hemiplegic limb comprehensive training, balance function training, limb neuromuscular electrical stimulation, acupuncture and other comprehensive rehabilitation treatments. Each project was 30 minutes/time, once a day, 5 days a week, and the treatment course was 4 weeks.comprehensive rehabilitation treatments, each item is 30 minutes/time, once a day, 5 days a week, and the treatment course is 4 weeks.
Eligibility Criteria
You may qualify if:
- Patients who meet the diagnostic criteria for stroke for the first time;
- Patients whose disease duration is within 6 months, have received specialist and standardized treatment, and have stable vital signs;
- Patients are informed of this study, voluntarily accept rehabilitation treatment, and sign an informed consent form;
- Patients who have no chronic breathing before and after stroke History of systemic and circulatory diseases.
- The patient can maintain the starting posture evaluated by the mTIS scale for 10 seconds. The standard for the starting posture is: sitting on the edge of the bed without any support for the back and arms, with the thighs in full contact with the bed surface, and with the feet flat and the same width as the hips. On the ground, bend your knees 90° and place your arms on your thighs .
You may not qualify if:
- Those who are complicated by severe heart, lung and other organ dysfunction diseases, such as pulmonary embolism, pacemaker placement, etc.;
- Those who are complicated by severe cognitive impairment and abnormal hearing and understanding;
- There are other reasons why electrical stimulation treatment is not suitable, Such as sudden unstable vital signs, malignant tumors, combined with mental illness, etc.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zhang liqionglead
Study Sites (1)
Zhangliqiong
Hefei, Anhui, 230032, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Liqiong Zhang
Anhui Medical University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- resident physician
Study Record Dates
First Submitted
December 13, 2023
First Posted
January 10, 2024
Study Start
February 13, 2023
Primary Completion
August 14, 2023
Study Completion
September 30, 2024
Last Updated
January 10, 2024
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share